找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials; Tony K.L. Kiang,Kyle John Wilby,Mary H.H. En

[復(fù)制鏈接]
樓主: 切口
31#
發(fā)表于 2025-3-26 21:45:11 | 只看該作者
32#
發(fā)表于 2025-3-27 04:14:24 | 只看該作者
The Roles of SUMO in Metabolic Regulationin 108 countries that are inhabited by approximately 3 billion people. The most recent estimates from the World Health Organization (WHO) (WHO 2014a, b) suggest there were approximately 207 million cases of malaria in 2012 and 627,000 deaths related to the disease. Most deaths occurred among childre
33#
發(fā)表于 2025-3-27 07:28:16 | 只看該作者
Amanda C. Nottke,Monica P. Colaiácovonergistic combinations and increased therapeutic success. A summary of pharmacological and pharmacokinetic considerations is given in Table 2.1 for chloroquine, amodiaquine, sulfadoxine, pyrimethamine, mefloquine, quinine/quinidine, artemisinin (the artemisinin agents, artemether, artesunate, and di
34#
發(fā)表于 2025-3-27 10:28:51 | 只看該作者
Sumo Modification of Ion Channelsalarials include the following: chloroquine, amodiaquine, sulfadoxine and pyrimethamine, mefloquine, primaquine, atovaquone, proguanil, quinine, artemisinin, artesunate, artemether, and dihydroartemisin.
35#
發(fā)表于 2025-3-27 15:08:48 | 只看該作者
36#
發(fā)表于 2025-3-27 20:19:16 | 只看該作者
37#
發(fā)表于 2025-3-28 00:13:07 | 只看該作者
Book 2010s.. . .Comprehensive coverage of the new greater and more challenging integration with .NET 3.5 . .Written from a real–world perspective and examines the features offered by LINQ and the Entity Framework that will help solve problems experienced by professional developers . .Contains insight, interp
38#
發(fā)表于 2025-3-28 04:20:10 | 只看該作者
39#
發(fā)表于 2025-3-28 09:00:00 | 只看該作者
40#
發(fā)表于 2025-3-28 12:29:25 | 只看該作者
Der It?-Kalkül978-3-540-29265-4Series ISSN 2731-3557 Series E-ISSN 2731-3565
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 23:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
衡水市| 山丹县| 蓝田县| 瑞丽市| 南通市| 丰县| 峨山| 宝山区| 加查县| 从江县| 正蓝旗| 绥江县| 海林市| 兴山县| 涞水县| 东平县| 墨竹工卡县| 荔波县| 鸡东县| 资溪县| 晴隆县| 万荣县| 永修县| 古丈县| 聂荣县| 疏勒县| 临城县| 东乌珠穆沁旗| 宿州市| 青岛市| 周宁县| 昌邑市| 长乐市| 大丰市| 都昌县| 珲春市| 肥城市| 蓬莱市| 奈曼旗| 平遥县| 深水埗区|